Estrogen Upregulates Endothelial Constitutive Nitric Oxide Synthase Expression in Human Osteoblast-Like Cells
Open accessThe DOI matches its Crossref record.
Abstract
The protective effects of estrogen on the cardiovascular system are thought to be mediated, in part, by nitric oxide (NO). Estrogen also has protective effects on bone although the mechanisms of action have not been fully established. Since nitric oxide synthase (NOS) inhibitors have been found to abrogate the protective effect of estrogen on bone in ovariectomised rats, we studied the effects of 17beta-estradiol on NOS activity and NOS mRNA levels in cultured human osteoblast-like cells. 17beta-Estradiol stimulated NOS activity by approximately 2.0 fold and this effect was reversed by the calcium chelator, EGTA, and the NOS inhibitor, L-NMMA, implicating activation of a constitutive, calcium-dependent isoform. Further studies using RT/PCR indicated that only the endothelial nitric oxide synthase (ecNOS) isoform was expressed and RNase protection assays showed that 17beta-Estradiol treatment resulted in a 2.2 fold increase in ecNOS mRNA levels. These findings suggest that estrogen stimulates NOS activity in osteoblastic cells by activation of the ecNOS pathway, and taken together with previous data, is consistent with the possibility that NO may act as a mediator of estrogen actions on bone.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Changes in Proinflammatory Cytokine Activity after Menopause
Pfeilschifter, J., Köditz, R., Pfohl, M., & Schatz, H. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.1.0456 · Cited by 914
Estrogen Modulation of Endothelial Nitric Oxide Synthase
Chambliss, K. L., & Shaul, P. W. (2002) · Endocrine Reviews · doi:10.1210/er.2001-0045 · Cited by 569
Van'T Hof, R. J., & Ralston, S. H. (2001) · Immunology · doi:10.1046/j.1365-2567.2001.01261.x · Cited by 518
Self-citationBalligand, J.-L., Feron, O., & Dessy, C. (2009) · Physiological Reviews · doi:10.1152/physrev.00042.2007 · Cited by 477
Local delivery of nitric oxide: Targeted delivery of therapeutics to bone and connective tissues
Nichols, S. P., Storm, W. L., Koh, A., & Schoenfisch, M. H. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.03.002 · Cited by 148
“As estrogen exerts some of its action by upregulating eNOS [43], the beneficial effects of estrogen on bonemineral density reversed when a NOS inhibitor such as L-NAME was administered.”
Evidence for a Pathogenic Role of Nitric Oxide in Inflammation-Induced Osteoporosis
Armour, K. E., Van 'T Hof, R. J., Grabowski, P. S., Reid, D. M., & Ralston, S. H. (1999) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1999.14.12.2137 · Cited by 133
“In bone cells, several factors including mechanical stress,((3)) estrogen,((4)) and proinflammatory cytokines such as interleukin-1 (IL-1), tumor necrosis factor alpha (TNF-a), and interferon gamma((5,6)) have been found to regulate NO production by stimulating different isoforms of nitric oxide synthase (NOS).”
BackgroundSelf-citationBakker, A. D., Klein-Nulend, J., Tanck, E., Albers, G. H., Lips, P., & Burger, E. H. (2005) · Osteoporosis International · doi:10.1007/s00198-004-1785-0 · Cited by 68
Mohd Effendy, N., Mohamed, N., Muhammad, N., Naina Mohamad, I., & Shuid, A. N. (2012) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2012/125761 · Cited by 55
“Apart from that, NO activity can be upregulated by estradiol [99].”
Background
Metadata
- Authors
- Armour, K. E.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 1998-02-01
- Volume
- 139
- Issue
- 2
- Pages
- 799-802
- ISSN
- 0013-7227 (ISSN-L)
- OpenAlex
- W2058403008
- Cited by
- 105
- References
- 0
- FWCI
- 5.31
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.